Niraparib bulk supplier for pharma manufacturers

Niraparib 100 mg, 200 mg, 300 mg Suppliers & Bulk Manufacturers

Available Forms: Capsule/ Tablet

Available Strengths: 100 mg, 200 mg, 300 mg

Reference Brands: Zejula (USA/EU)

Niraparib is an oral PARP inhibitor used for the treatment and maintenance of advanced ovarian, fallopian tube, or primary peritoneal cancer. It works by blocking the PARP enzyme, which helps repair DNA damage in cancer cells, leading to cell death, especially in tumors with BRCA mutations or homologous recombination deficiency (HRD). Niraparib is available in capsules or tablets and is taken once daily, with the dose adjusted based on body weight and platelet count. It helps delay cancer progression and is generally used after platinum-based chemotherapy.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Niraparib — third party manufacturing & bulk supply

Niraparib 100 mg, 200 mg, 300 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Niraparib is supplied as Capsule/ Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Niraparib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Niraparib →

Back to Listing

Frequently Asked Questions

Niraparib is listed as Capsule/ Tablet in 100 mg, 200 mg, 300 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Niraparib is referenced against Zejula (USA/EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.